PRFX
PRF Technologies Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.97
−1.14%Latest reported
- Last report date
- Oct 2, 2025
- EPS actual
- -$9.60
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -2106.7%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jul 2, 2026